Review of recommendations on prophylactic antibiotic use in cesarean section-A Review Article

Wound infection is a typical, partly preventable complication of cesarean sections. We started extended recording of cesarean section data in October, 2008 as part of our general wound infection surveillance program. Aim: To describe the circumstances and outcomes of the sections and analyze associations between them. Methods: We analyzed 523 cases over the period October 1, 2008 to September 30, 2009. Variables were assessed using descriptive statistics. Associations between explanatory factors and wound infection were evaluated using logistic regression. Results: Infections (overall rate: 3.6%) were more frequent in younger subjects, those with anemia, subcutaneous hematoma, in pregnancies with meconium stained or purulent amniotic fluid, and decreased to about a third after infection control was tightened. Conclusions: by being a proxy variable of factors with which wound infection is associated, age is a clinically valuable predictive variable. Good infection control practice is effective in preventing wound infections. The results are consistent with appropriate prescription practices of prophylactic antibiotic use, and with prophylactic measures being effective. Orv. Hetil., 2011, 152, 14–22.

Download Full-text

Pseudomembranous colitis following prophylactic antibiotic use in primary cesarean section

American Journal of Obstetrics and Gynecology ◽

10.1016/0002-9378(85)90430-2 ◽

1985 ◽

Vol 151 (1) ◽

pp. 87-89 ◽

Cited By ~ 13

Author(s):

Edward L. Arsura ◽

Richard A. Fazio ◽

Prasanna C. Wickremesinghe

Keyword(s):

Cesarean Section ◽

Pseudomembranous Colitis ◽

Prophylactic Antibiotic ◽

Antibiotic Use

Download Full-text

EVALUASI PENGGUNAAN ANTIBIOTIK PROFILAKSIS PADA PASIEN BEDAH SESAR (SECTIO CAESAREA) DI RSUD ULIN BANJARMASIN TAHUN 2017

Jurnal Ilmiah Manuntung ◽

10.51352/jim.v5i2.263 ◽

2020 ◽

Vol 5 (2) ◽

pp. 146

Author(s):

Saftia Aryzki ◽

Hidayatun Nisa ◽

Dian Yunita Gamaliana

Keyword(s):

Cesarean Section ◽

Medical Records ◽

Prophylactic Antibiotic ◽

Antibiotic Use ◽

Total Sample ◽

Prophylactic Antibiotics ◽

Sectio Caesarea ◽

Record Data ◽

Experimental Type ◽

Third Generation Cephalosporins

Cesarean section (Sectio Caesarea) is an attempt to remove the fetus through surgery on the abdominal wall and uterus. The use of inappropriate prophylactic antibiotics will lead to infection and resistance. The purpose of this study was to determine prophylactic antibiotic use, in cesarean section patients, to know prophylactic antibiotic use in cesarean section patients in accordance with antibiotic use guidelines (PPAB) Ulin Hospital in 2017, to know prophylactic antibiotic use in cesarean section patients in accordance with Permenkes RI Number 2406 / PER / XII / 2011. This research is a non-experimental type of descriptive study retrospectively by taking medical record data of cesarean section patients at Ulin Banjarmasin Hospital in 2017 with saturated sampling method, obtained a population of 99 medical records of cesarean section with a total sample of 99 medical records. The use of prophylactic antibiotics in Ulin Banjarmasin Public Hospital is a class of third generation cephalosporins namely ceftriaxone and cefotaxime with doses of 1-2 grams / day and duration of 3-5 days. Comparison of the percentage of prophylactic antibiotic use with the guidelines for drug use in Ulin Hospital in Banjarmasin in 2017 is the name and class of 100% is appropriate and 0% is not appropriate, the dose is 100% appropriate and 0% is not appropriate, the duration of administration is 69.70% is appropriate and 30.30% is not corresponding. Comparison of the percentage of prophylactic antibiotic use with Permenkes RI Number 2406 / PER / XII / 2011 is the name and class of 0% is appropriate and 100% is not appropriate, the dose is 0% is appropriate and 100% is not appropriate, the duration of giving 0% is appropriate and 100 % it is not in accordance with.

Download Full-text

Analysis of Prophylactic Antibiotics Usage in Caesarean Section Delivery

Folia Medica Indonesiana ◽

10.20473/fmi.v54i3.10004 ◽

2018 ◽

Vol 54 (3) ◽

pp. 161

Author(s):

Binti Muzayyanah ◽

Yulistiani Yulistiani ◽

Didik Hasmono ◽

Nuraida Wisudani

Keyword(s):

Caesarean Section ◽

Cesarean Section ◽

First Generation ◽

Prophylactic Antibiotic ◽

Antibiotic Use ◽

Developed Countries ◽

The United States ◽

Prophylactic Antibiotics ◽

Surgical Incision ◽

Caesarean Section Delivery

Caesarean section is the delivery through a surgical incision in the abdomen and uterus with various risks, such as Surgical Site Infection (SSI) which either occurs rapidly (24-48 hours postoperatively) or delayed. To reduce the risk of various post-cesarean section infections, prophylactic antibiotics are given. The administration of prophylactic antibiotics with recommended regimens, such as in developed countries as in the United States and Europe, with first generation of cephalosporins has not been applied in Dr. Iskak Hospital, Tulungagung. This hospital still used other types of antibiotics, such as cefotaxime or ceftriaxone. In addition, for several reasons, prophylactic antibiotics were continued with other antibiotics to reduce the risk of delayed infection. This study was designed to analyze the effectiveness of prophylactic antibiotics as recommended in cesarean section. This was a prospective observational study with consecutive sampling type, examined 41 mothers with cesarean section at the Department of Obstretics and Gynecology, Dr. Iskak Hospital, Tulungagung, Indonesia. This study was conducted from May to July, 2017. The results of the study showed that the effectiveness of prophylactic antibiotic use was 98% based on the clinical parameters and maternal laboratory outcome, which showed that SIRS was in normal category. Whereas, there was one mother (2%) who had SSI on day 10 postoperatively.

Download Full-text

Is perioperative antibiotic necessary in straightforward implant placement procedures?

Journal of Oral Implantology ◽

10.1563/aaid-joi-d-19-00282 ◽

2020 ◽

Author(s):

Elçin Bedeloğlu ◽

Mustafa Yalçın ◽

Cenker Zeki Koyuncuoğlu

Keyword(s):

Clavulanic Acid ◽

Dental Implant ◽

Prophylactic Antibiotic ◽

Antibiotic Use ◽

Implant Failure ◽

Control Group ◽

Implant Placement ◽

Significant Difference ◽

Amoxicillin Clavulanic Acid ◽

Experimental Group

The purpose of this non-random retrospective cohort study was to evaluate the impact of prophylactic antibiotic on early outcomes including postoperative pain, swelling, bleeding and cyanosis in patients undergoing dental implant placement before prosthetic loading. Seventy-five patients (45 males, 30 females) whose dental implant placement were completed, included to the study. Patients used prophylactic antibiotics were defined as the experimental group and those who did not, were defined as the control group. The experimental group received 2 g amoxicillin + clavulanic acid 1 h preoperatively and 1 g amoxicillin + clavulanic acid twice a day for 5 days postoperatively while the control group had received no prophylactic antibiotic therapy perioperatively. Data on pain, swelling, bleeding, cyanosis, flap dehiscence, suppuration and implant failure were analyzed on postoperative days 2, 7, and 14 and week 12. No statistically significant difference was detected between the two groups with regard to pain and swelling on postoperative days 2, 7, and 14 and week 12 ( p >0.05), while the severity of pain and swelling were greater on day 2 compared to day 7 and 14 and week 12 in both groups ( p =0.001 and p <0.05, respectively). Similarly, no significant difference was found between the two groups with regard to postoperative bleeding and cyanosis. Although flap dehiscence was more severe on day 7 in the experimental group, no significant difference was found between the two groups with regard to the percentage of flap dehiscence assessed at other time points. Within limitations of the study, it has been demonstrated that antibiotic use has no effect on implant failure rates in dental implant surgery with a limited number of implants. We conclude that perioperative antibiotic use may not be required in straightforward implant placement procedures. Further randomized control clinical studies with higher numbers of patients and implants are needed to substantiate our findings.

Download Full-text